Amgen 2024 J.P. Morgan Healthcare Conference Presentation

Amgen presented at the 42nd Annual J.P. Morgan Healthcare Conference on January 8, 2024, with remarks from Chairman and CEO Robert A. Bradway. The presentation discussed forward-looking statements regarding product performance, acquisitions including Horizon Therapeutics, and strategic collaborations in oncology and other therapeutic areas. Topics included revenue guidance, operating margins, clinical developments, and market positioning across the company's portfolio.